Friday, October 30, 2026 · Edition updated 6:00 AM ETFRI, OCT 30 · 6 AM ET editionNext edition in Next --:--:--

A humanin analog eased kidney damage in diabetic mice and cells

A study · European journal of pharmacology · Jul 23, 2026

What this means

Researchers found a treated protein reduced kidney damage and cell death in diabetic mice. This work was in mice and cells, so it does not show the same effect in people.

Plain-English summary written by an AI model from the abstract. The original is below.

Tested inAnimals
Who it was tested in
Diabetic mice, two other mouse models, human kidney cells in a lab, and kidney tissue from DN patients
Kind of research
A study

The science

Original title
S14G-humanin (HNG) ameliorates diabetic nephropathy tubular injury by inhibiting Z-DNA/ZBP1-mediated necroptosis.
Authors
Liu Y, Hu C, Luo S et al.
Journal
European journal of pharmacology
Published
Jul 23, 2026
Study type
Study · in humans

Abstract

Background

Diabetic nephropathy (DN) is the leading cause of end-stage renal disease, with limited therapeutic options. S14G-humanin (HNG), a potent analog of humanin, exerts protective effects in various diseases, but its role in DN remains unexplored.

What they did

DN was induced in C57BL/6 mice via high-fat diet and streptozotocin (STZ), with or without HNG treatment. Renal injury, necroptosis, and Z-DNA/ZBP1 pathways were evaluated by histology, western blotting, and transcriptomics, and key findings were validated in db/db mice and high glucose/palmitate (HG + PA)-treated HK-2 cells.

What they found

HNG treatment dose-dependently alleviated renal injury in DN mice. Specifically, high-dose-HNG significantly reduced the urinary albumin-to-creatinine ratio (UACR) by 49.5% (from 103.91 ± 7.68 to 52.50 ± 4.02 μg/mg, P < 0.001) and alleviated renal pathological injury compared to untreated DN mice. Mechanistically, transcriptomics and immunoblotting revealed that HNG markedly inhibited tubular necroptosis, as evidenced by a 52.2% reduction in p-MLKL expression (P < 0.001). HNG also suppressed mitochondrial BAX translocation, reduced mitochondrial ROS production, and blocked mitochondrial Z-DNA leakage, which consequently abrogated ZBP-1 upregulation and ZBP1-mediated necroptosis. These protective effects were corroborated in db/db diabetic mice and HG + PA-challenged HK-2 tubular cells. Moreover, ZBP1 was markedly upregulated, with increased p-MLKL expression in renal tubules of DN patients compared to controls (P < 0.05). HNG ameliorates DN tubular injury by inhibiting BAX-driven mitochondrial oxidative stress and subsequent Z-DNA/ZBP1-mediated necroptosis, highlighting HNG as a promising therapeutic candidate for DN.

The authors' abstract, grouped under plain headings from its own section labels.

Read it on PubMed ↗

Liu Y, Hu C, Luo S et al. S14G-humanin (HNG) ameliorates diabetic nephropathy tubular injury by inhibiting Z-DNA/ZBP1-mediated necroptosis. European journal of pharmacology. 2026. doi:10.1016/j.ejphar.2026.179175. PMID: 42492881. https://pubmed.ncbi.nlm.nih.gov/42492881/

Related research

Study · Biology · Jul 15, 2026

Humanin treatment eased heart damage in diabetic mice

Mice with diabetes that got daily humanin for 15 days had less stress, inflammation, and cell death in the heart. This was tested in mice only, so it does not show the same would happen in people.

Study · Biomolecules · Jul 28, 2026

Humanin protein family may help steer cell stress responses

Researchers mapped how Humanin-related proteins connect to other proteins in a computer network. They suggest these proteins may guide stress responses, not just act alone. This is a model, so it does not show these proteins work this way in people.

Study · Reproduction (Cambridge, England) · Jul 3, 2026

Humanin, a small mitochondrial peptide, protected ovary cells from oxidative damage in lab tests

Researchers found that humanin helped human ovary cells and rat ovary tissue survive damage from oxidative stress. This was tested in cells and tissue, not people, so it does not show effects in humans.

Study · Antioxidants (Basel, Switzerland) · Aug 27, 2026

AGEs-RAGE Axis and Mitochondrial-Derived Peptides in Advanced Chronic Kidney Disease: Interconnected Pathways Beyond Inflammation and Nutrition.

Background. Chronic kidney disease [CKD] is characterized by increased glycoxidative stress, inflammation, and mitochondrial dysfunction.

Summary of earlier studiesReview · Epigenomics · Aug 11, 2026

Emerging regulators of human physiology and disease; sORF-encoded microproteins.

The human genome contains hundreds of thousands of short open reading frames (sORFs), yet their translational products, hereafter referred to as sORF-encoded microproteins (also historically termed micropeptides), have…

Summary of earlier studiesReview · Frontiers in immunology · Sep 22, 2026

The MTRNR2L gene family and age-related macular degeneration.

Age-related macular degeneration (AMD) is the leading cause of blindness in aging adults, yet no FDA-approved therapies exist for early and intermediate disease.

See all research on Humanin →

Report a problem